Dido, Norham L.
HRN: 23-59-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
CEFOTAXIME 500MG (VIAL)
09/03/2023
09/10/2023
IV
115mg
Q12hours
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes